124.55€
0.00€ (0.00%)
End-of-day quote: 04/30/2024
ENXTBR:UCB
UCB Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $776.75 | $636.99 | 0.00% | 9 | $699.39B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $151.18 | $174.55 | 0.00% | 3 | $364.31B |
| MRK | Merck | NYSE | Outperform | $128.80 | $130.51 | 0.00% | 11 | $326.25B |
| ABBV | AbbVie | NYSE | Outperform | $161.72 | $178.42 | 0.00% | 11 | $286.35B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $574.99 | $591.94 | 0.00% | 1 | $219.48B |
| NOVN | Novartis | SWX | Hold | CHF89.05 | CHF105.00 | 0.00% | 9 | CHF181.70B |
| AMGN | Amgen | NasdaqGS | Outperform | $277.37 | $303.65 | 0.00% | 8 | $148.77B |
| SAN | Sanofi | ENXTPA | Outperform | 93.08€ | 102.80€ | 0.00% | 9 | 116.22€B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.21 | $58.15 | 0.00% | 10 | $89.62B |
| CSL | CSL | ASX | Outperform | $274.49 | $205.51 | 0.00% | 5 | $132.65B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.51 | $87.82 | 0.00% | 14 | $81.69B |
| SHW | Sherwin Williams | NYSE | Outperform | $303.34 | $317.38 | 0.00% | 9 | $76.94B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.14k | ¥4.74k | 0.00% | 0 | ¥6.50T |
| LONN | Lonza Group | SWX | Buy | CHF510.40 | CHF516.89 | 0.00% | 8 | CHF36.81B |
| PPG | PPG Industries | NYSE | Outperform | $130.95 | $159.04 | 0.00% | 1 | $30.82B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $13.98 | $11.59 | 0.00% | 9 | $15.83B |
| 4523 | Eisai | TSE | Outperform | ¥6.55k | ¥9.58k | 0.00% | 0 | ¥1.86T |
| INCY | Incyte | NasdaqGS | Outperform | $52.94 | $77.05 | 0.00% | 8 | $11.89B |
| CRDA | Croda International Plc | LSE | Outperform | £46.19 | £65.12 | 0.00% | 6 | £6.43B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $46.05 | $79.81 | 0.00% | 3 | $5.59B |
| WCH | Wacker Chemie | XTRA | Outperform | 100.60€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF13.78 | CHF16.11 | 0.00% | 6 | CHF4.53B |
| OMER | Omeros | NasdaqGM | Hold | $3.40 | $13.00 | 0.00% | 2 | $182.52M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $1.11 | $3.26 | 0.00% | 1 | $158.26M |
| DXB | Dimerix | ASX | $0.32 | $0.00 | 0.00% | 0 | $159.38M | |
| BLRX | BioLineRx | TASE | - | ₪0.18 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.41 | $9.44 | 0.00% | 2 | $79.49M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.70 | $80.00 | 0.00% | 0 | $9.39M |
